Michael J. La Barre Halozyme Therapeutics, Inc. (HALO) insider trading activity

Michael J. La Barre is SVP, CHIEF TECHNICAL OFFICER of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 173,756 shares of HALO, which is worth approximately $10.3 Million. The most recent transaction as insider was on Feb 12, 2022, when has been sold 2,725 shares (Common Stock) at a price of $34.2 per share, resulting in proceeds of $93,195. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K

3.32% 3M change

14.38% 12M change

Total Value Held $10.3 Million

Michael J. LaBarre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2022	SELL Payment of exercise price or tax liability	$93,195 $34.2 p/Share	2,725 Reduced 1.6%	167,145 Common Stock
Feb 12 2022	BUY Exercise of conversion of derivative security	-	7,883 Added 4.43%	169,870 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$104,540 $34.94 p/Share	2,992 Reduced 1.81%	161,987 Common Stock
Feb 10 2022	BUY Exercise of conversion of derivative security	-	8,133 Added 4.7%	164,979 Common Stock
Oct 12 2021	BUY Exercise of conversion of derivative security	$105,455 $13.1 p/Share	8,050 Added 4.88%	156,846 Common Stock
Oct 01 2021	SELL Open market or private sale	$1,175,939 $39.93 p/Share	29,450 Reduced 16.52%	148,796 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$385,795 $13.1 p/Share	29,450 Added 14.18%	178,246 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$96,187 $6.55 p/Share	14,685 Added 8.98%	148,796 Common Stock
Jul 01 2021	SELL Open market or private sale	$1,842,396 $45.7 p/Share	40,315 Reduced 23.11%	134,111 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$264,063 $6.55 p/Share	40,315 Added 18.77%	174,426 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$127,701 $11.29 p/Share	11,311 Added 7.78%	134,111 Common Stock
Apr 01 2021	SELL Open market or private sale	$1,217,848 $42.45 p/Share	28,689 Reduced 18.94%	122,800 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$323,899 $11.29 p/Share	28,689 Added 15.92%	151,489 Common Stock
Mar 01 2021	SELL Open market or private sale	$841,255 $45.91 p/Share	18,324 Reduced 12.98%	122,800 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$212,483 $48.69 p/Share	4,364 Reduced 3.0%	141,124 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	8,803 Added 5.71%	145,488 Common Stock
Feb 14 2021	SELL Payment of exercise price or tax liability	$113,236 $49.84 p/Share	2,272 Reduced 1.64%	136,685 Common Stock
Feb 14 2021	BUY Exercise of conversion of derivative security	-	5,771 Added 3.99%	138,957 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$135,814 $49.84 p/Share	2,725 Reduced 2.0%	133,186 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	7,883 Added 5.48%	135,911 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$147,044 $50.6 p/Share	2,906 Reduced 2.22%	128,028 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	-	8,134 Added 5.85%	130,934 Common Stock
Dec 21 2020	SELL Open market or private sale	$514,800 $42.9 p/Share	12,000 Reduced 8.9%	122,800 Common Stock
Nov 20 2020	SELL Open market or private sale	$463,680 $38.64 p/Share	12,000 Reduced 8.17%	134,800 Common Stock
Oct 20 2020	SELL Open market or private sale	$365,160 $30.43 p/Share	12,000 Reduced 7.56%	146,800 Common Stock

MJL

Michael J. La Barre

SVP, CHIEF TECHNICAL OFFICER

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Value

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO

Account